Skip to content

CONMED CNMD Repayments of Senior Debt

Repayments of Senior Debt at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
Globus Medical logo
Globus MedicalGMED
STERIS logo
STERISSTE

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfSeniorDebt.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's repayments of senior debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's repayments of senior debt?
CONMED (CNMD) reported repayments of senior debt of $0 in Q1 2026.
How has CONMED's repayments of senior debt changed year-over-year?
CONMED's repayments of senior debt decreased by 100.0% year-over-year, from $14.59M to $0.
What is the long-term trend for CONMED's repayments of senior debt?
Over 3 years (2021 to 2025), CONMED's repayments of senior debt has grown at a 14.4% compound annual growth rate (CAGR), from $66.65M to $99.82M.